Related Experiment Video
Updated: May 17, 2026
06:40
A Robust Method for the Large-Scale Production of Spheroids for High-Content Screening and Analysis Applications
Published on: December 28, 2021
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin1, Lorraine O'Driscoll
1School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Drug Discovery Today
|October 18, 2012
Summary
Two-dimensional (2D) cell cultures are standard for initial drug screening, but three-dimensional (3D) models offer greater clinical relevance for anti-cancer drug development by better mimicking in vivo conditions.
Area of Science:
- Oncology
- Cell Biology
- Drug Discovery
Background:
- Two-dimensional (2D) cell cultures are widely used for initial therapeutic molecule screening.
- These 2D models are crucial for early 'stop/go' decisions in drug development pipelines.
- Current 2D methods may not fully represent in vivo cellular environments.
Purpose of the Study:
- To review and compare 2D and 3D cell culture approaches for anti-cancer drug screening.
- To evaluate the strengths and clinical relevance of each culture method.
Main Methods:
- Review of existing literature on 2D cell monolayer cultures.
- Analysis of three-dimensional (3D) cell culture models, including co-culture systems.
- Consideration of cellular microenvironments in 3D models.
Main Results:
- 2D cultures provide a foundational screening platform.
- 3D cultures, more analogous to in vivo conditions (e.g., tumors), offer enhanced clinical relevance.
- The choice of culture method impacts the interpretation of drug effectiveness and safety.
Conclusions:
- 3D cell culture models represent a more clinically relevant approach for anti-cancer drug screening.
- Integrating 3D models, potentially with co-culture components, can improve preclinical assessments.
- Further research into optimizing 3D culture systems is warranted for advancing drug development.
